Swapneel Anaokar

Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study

F. Lehner, F. Nevens, W. Bechstein, 2021, Transplantation direct.

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study

O. Viklicky, O. Witzke, D. Kuypers, 2023, Transplantation direct.

Long‐term, prolonged‐release tacrolimus‐based immunosuppression in de novo kidney transplant recipients: 5‐year prospective follow‐up of the ADHERE study patients

F. Lehner, M. Christiaans, J. Klempnauer, 2019, Transplant international : official journal of the European Society for Organ Transplantation.

Efficacy of Prolonged-release Tacrolimus After Conversion From Immediate-release Tacrolimus in Kidney Transplantation: A Retrospective Analysis of Long-term Outcomes From the ADMIRAD Study

M. Blogg, Swapneel Anaokar, N. Kanaan, 2023, Transplantation direct.

Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients

N. Kamar, N. Undre, F. Saliba, 2020, Therapeutic drug monitoring.

Long-Term Outcomes with Prolonged-Release Tacrolimus in Kidney Transplantation: A Retrospective Real-World Data Analysis

W. Gwinner, Swapneel Anaokar, Mario Schiffer, 2024, Annals of transplantation.